Kasabach-Merritt phenomenon

Khalid A. Al-Mazrou, Mark A. Richardson

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

An association between a vascular lesion and a life threatening coagulopathy is called Kasabach-Merritt phenomenon (KMP). It includes thrombocytopenia, microangiopathic hemolytic anemia, and disseminated intravascular coagulopathy. We cannot overstate the need for excellent and careful screening. Treatment modalities of KMP have included medication, radiation, embolization and surgery. Corticosteroids have traditionally been the mainstay of treatment. We report a 4-month-old girl with an extensive vascular lesion involving the left parotid, submandibular, and parapharyngeal regions, and with KMP. We treated her with a mega dose of corticosteroids. Her coagulopathy resolved, and her vascular lesion improved.

Original languageEnglish (US)
Pages (from-to)1286-1288
Number of pages3
JournalSaudi Medical Journal
Volume26
Issue number8
StatePublished - Aug 2005

Fingerprint

Kasabach-Merritt Syndrome
Blood Vessels
Adrenal Cortex Hormones
Hemolytic Anemia
Thrombocytopenia
Radiation
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Al-Mazrou, K. A., & Richardson, M. A. (2005). Kasabach-Merritt phenomenon. Saudi Medical Journal, 26(8), 1286-1288.

Kasabach-Merritt phenomenon. / Al-Mazrou, Khalid A.; Richardson, Mark A.

In: Saudi Medical Journal, Vol. 26, No. 8, 08.2005, p. 1286-1288.

Research output: Contribution to journalArticle

Al-Mazrou, KA & Richardson, MA 2005, 'Kasabach-Merritt phenomenon', Saudi Medical Journal, vol. 26, no. 8, pp. 1286-1288.
Al-Mazrou KA, Richardson MA. Kasabach-Merritt phenomenon. Saudi Medical Journal. 2005 Aug;26(8):1286-1288.
Al-Mazrou, Khalid A. ; Richardson, Mark A. / Kasabach-Merritt phenomenon. In: Saudi Medical Journal. 2005 ; Vol. 26, No. 8. pp. 1286-1288.
@article{ec7c9c21dcaf4cc3a7976aebc56e7b4d,
title = "Kasabach-Merritt phenomenon",
abstract = "An association between a vascular lesion and a life threatening coagulopathy is called Kasabach-Merritt phenomenon (KMP). It includes thrombocytopenia, microangiopathic hemolytic anemia, and disseminated intravascular coagulopathy. We cannot overstate the need for excellent and careful screening. Treatment modalities of KMP have included medication, radiation, embolization and surgery. Corticosteroids have traditionally been the mainstay of treatment. We report a 4-month-old girl with an extensive vascular lesion involving the left parotid, submandibular, and parapharyngeal regions, and with KMP. We treated her with a mega dose of corticosteroids. Her coagulopathy resolved, and her vascular lesion improved.",
author = "Al-Mazrou, {Khalid A.} and Richardson, {Mark A.}",
year = "2005",
month = "8",
language = "English (US)",
volume = "26",
pages = "1286--1288",
journal = "Saudi Medical Journal",
issn = "0379-5284",
publisher = "Saudi Arabian Armed Forces Hospital",
number = "8",

}

TY - JOUR

T1 - Kasabach-Merritt phenomenon

AU - Al-Mazrou, Khalid A.

AU - Richardson, Mark A.

PY - 2005/8

Y1 - 2005/8

N2 - An association between a vascular lesion and a life threatening coagulopathy is called Kasabach-Merritt phenomenon (KMP). It includes thrombocytopenia, microangiopathic hemolytic anemia, and disseminated intravascular coagulopathy. We cannot overstate the need for excellent and careful screening. Treatment modalities of KMP have included medication, radiation, embolization and surgery. Corticosteroids have traditionally been the mainstay of treatment. We report a 4-month-old girl with an extensive vascular lesion involving the left parotid, submandibular, and parapharyngeal regions, and with KMP. We treated her with a mega dose of corticosteroids. Her coagulopathy resolved, and her vascular lesion improved.

AB - An association between a vascular lesion and a life threatening coagulopathy is called Kasabach-Merritt phenomenon (KMP). It includes thrombocytopenia, microangiopathic hemolytic anemia, and disseminated intravascular coagulopathy. We cannot overstate the need for excellent and careful screening. Treatment modalities of KMP have included medication, radiation, embolization and surgery. Corticosteroids have traditionally been the mainstay of treatment. We report a 4-month-old girl with an extensive vascular lesion involving the left parotid, submandibular, and parapharyngeal regions, and with KMP. We treated her with a mega dose of corticosteroids. Her coagulopathy resolved, and her vascular lesion improved.

UR - http://www.scopus.com/inward/record.url?scp=24744446268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24744446268&partnerID=8YFLogxK

M3 - Article

VL - 26

SP - 1286

EP - 1288

JO - Saudi Medical Journal

JF - Saudi Medical Journal

SN - 0379-5284

IS - 8

ER -